These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26881020)

  • 1. It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease.
    Tramutola A; Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Oxid Med Cell Longev; 2016; 2016():2756068. PubMed ID: 26881020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome and its role in the degradation of oxidized proteins.
    Jung T; Grune T
    IUBMB Life; 2008 Nov; 60(11):743-52. PubMed ID: 18636510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of proteasome-mediated protein degradation during oxidative stress and aging.
    Breusing N; Grune T
    Biol Chem; 2008 Mar; 389(3):203-9. PubMed ID: 18208355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasomal defense of oxidative protein modifications.
    Poppek D; Grune T
    Antioxid Redox Signal; 2006; 8(1-2):173-84. PubMed ID: 16487051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.
    Tramutola A; Di Domenico F; Barone E; Arena A; Giorgi A; di Francesco L; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
    Antioxid Redox Signal; 2017 Mar; 26(7):280-298. PubMed ID: 27627691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
    Di Domenico F; Coccia R; Cocciolo A; Murphy MP; Cenini G; Head E; Butterfield DA; Giorgi A; Schinina ME; Mancuso C; Cini C; Perluigi M
    Biochim Biophys Acta; 2013 Aug; 1832(8):1249-59. PubMed ID: 23603808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein oxidative modification in the aging organism and the role of the ubiquitin proteasomal system.
    Kastle M; Grune T
    Curr Pharm Des; 2011 Dec; 17(36):4007-22. PubMed ID: 22188451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
    Hong L; Huang HC; Jiang ZF
    Neurol Res; 2014 Mar; 36(3):276-82. PubMed ID: 24512022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases.
    Davies KJ; Shringarpure R
    Neurology; 2006 Jan; 66(2 Suppl 1):S93-6. PubMed ID: 16432154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Proteasome and Its Network: Engineering for Adaptability.
    Finley D; Prado MA
    Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 30833452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative protein damage and the proteasome.
    Grimm S; Höhn A; Grune T
    Amino Acids; 2012 Jan; 42(1):23-38. PubMed ID: 20556625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
    Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
    Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein degradation by the proteasome and its implications in aging.
    Friguet B; Bulteau AL; Chondrogianni N; Conconi M; Petropoulos I
    Ann N Y Acad Sci; 2000 Jun; 908():143-54. PubMed ID: 10911955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging and calorie restriction modulate yeast redox state, oxidized protein removal, and the ubiquitin-proteasome system.
    da Cunha FM; Demasi M; Kowaltowski AJ
    Free Radic Biol Med; 2011 Aug; 51(3):664-70. PubMed ID: 21684330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes.
    Cecarini V; Bonfili L; Amici M; Angeletti M; Keller JN; Eleuteri AM
    Brain Res; 2008 May; 1209():8-18. PubMed ID: 18400214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
    Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
    J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
    Gong B; Leznik E
    Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox control of the ubiquitin-proteasome system: from molecular mechanisms to functional significance.
    Kriegenburg F; Poulsen EG; Koch A; Krüger E; Hartmann-Petersen R
    Antioxid Redox Signal; 2011 Oct; 15(8):2265-99. PubMed ID: 21314436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.
    Graham SH; Liu H
    Ageing Res Rev; 2017 Mar; 34():30-38. PubMed ID: 27702698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.